THERION BIOLOGICS CORPORATION;THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
发明人:
PANICALI, DENNIS L.,MAZZARA, GAIL P.,GRITZ, LINDA R.,TSANG, KWONG-YOK,SCHLOM, JEFFREY,HODGE, JAMES W.
申请号:
CA2545183
公开号:
CA2545183C
申请日:
2004.11.12
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
The present invention is directed to a system for treating individuals at riskof developing or suffering from pancreatic cancer. The system comprisesadministering to the individual a recombinant poxvirus, where the poxviruscontains a foreign nucleic acid encoding at least one pancreatic tumorassociated antigen (PTAA).